---
title: "Dynachem Pharmaceuticals (Export) Ltd (DYNAPHARMA) — Share Price, Financials & Analysis"
symbol: "DYNAPHARMA"
company: "Dynachem Pharmaceuticals (Export) Ltd"
canonical: "https://tapetide.com/stocks/DYNAPHARMA"
bse_code: "524562"
generated_at: "2026-10-13T10:59:12.224Z"
---

# Dynachem Pharmaceuticals (Export) Ltd (DYNAPHARMA)

Canonical page: https://tapetide.com/stocks/DYNAPHARMA

## Company

- **BSE Code:** 524562
- **Stock Type:** EQUITY
- **Face Value:** ₹10
- **F&O Eligible:** No

## About

Dynachem Pharmaceuticals (Export) Ltd. is engaged in the business of manufacture of chemical products.

## Latest Price

## Key Insights

### Strengths

- Company is almost debt free.

### Weaknesses

- Company has a low return on equity of 0.03% over last 3 years.
- Working capital days have increased from 10,318 days to 17,885 days

## Growth Rates

| Metric | 1Y |
| --- | --- |
| net income growth | -100% |
| revenue growth | -85% |

## Financial Statements

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2009 | Mar 2010 | Mar 2011 |
| --- | --- | --- | --- |
| Sales | 0.13 | 0.13 | 0.02 |
| Expenses | 0.13 | 0.12 | 0.02 |
| Operating Profit | 0 | 0.01 | 0 |
| OPM % | 0 | 7.69 | 0 |
| Other Income | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 |
| Profit before tax | 0 | 0.01 | 0 |
| Tax % | — | 0 | — |
| Net Profit | 0 | 0.01 | 0 |
| Dividend Payout % | — | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2009 | Mar 2010 | Mar 2011 |
| --- | --- | --- | --- |
| Equity Capital | 11.58 | 11.58 | 11.58 |
| Reserves | -0.21 | -0.2 | -0.2 |
| Borrowings | 0 | 0 | 0 |
| Other Liabilities | 0 | 0 | 0 |
| Total Liabilities | 11.37 | 11.38 | 11.38 |
| Fixed Assets | 2.68 | 2.68 | 2.68 |
| CWIP | 0 | 0 | 0 |
| Investments | 7.94 | 6.96 | 6.96 |
| Other Assets | 0.75 | 1.74 | 1.74 |
| Total Assets | 11.37 | 11.38 | 11.38 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2009 | Mar 2010 | Mar 2011 |
| --- | --- | --- | --- |
| Cash from Operating Activity | 0 | -0.97 | — |
| Cash from Investing Activity | -0.18 | 0.99 | — |
| Cash from Financing Activity | 0 | 0 | — |
| Net Cash Flow | -0.18 | 0.02 | — |
| Free Cash Flow | 0 | -0.97 | — |
| CFO/OP | — | -9700 | — |

### Ratios

| Item | Mar 2009 | Mar 2010 | Mar 2011 |
| --- | --- | --- | --- |
| Debtor Days | 0 | 0 | 0 |
| Inventory Days | 0 | 0 | — |
| Cash Conversion Cycle | 0 | 0 | 0 |
| Working Capital Days | 0 | 2751.54 | 17885 |
| ROCE % | — | 0.09 | 0 |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-10-13T10:59:12.224Z.